SEPTInvestingStart Free

TSHA 10-Q: SEC filing

Taysha Gene Therapies

Filed with the SEC on · accession 0001193125-26-456949

TSHA filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. Taysha Gene Therapies filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, debt agreements, and equity activity.

Summary of the filing

Taysha Gene Therapies filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, debt agreements, and equity activity. No single material corporate event is identifiable from the filing metadata.

For details, click here →How to read a 10-Q →

Key details

FilerTaysha Gene Therapies, Inc.
LenderTrinity Lenders
CounterpartyAstellas
CounterpartyAbeona Therapeutics Inc.

✦ Ask GOAX AI about this filing — what it means for TSHA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TSHA?

Click here

Frequently asked questions

What did TSHA file with the SEC on Nov 12, 2026?

TSHA filed a 10-Q (SEC filing). Taysha Gene Therapies filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, debt agreements, and equity activity. No single material corporate event is identifiable from the filing metadata.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other TSHA SEC filings

Get alerts when TSHA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
TSHA overviewTSHA analysisTSHA newsLatest SEC filings